Search in:

OncoImmunology Volume 9, 2020 - Issue 1

Submit an article Journal homepage

Open access

4,035

Views

CrossRef citations to date

Altmetric

Back Matter

Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1

Lijun Xua College of Medical, Henan University of Science and Technology, Luoyang, Henan, ChinaView further author information

Shanlong Wangb Department of Clinical Laboratory, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, ChinaView further author information

Jufeng Lib Department of Clinical Laboratory, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, ChinaView further author information

Jie Lib Department of Clinical Laboratory, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, ChinaView further author information

Bingyu Lia College of Medical, Henan University of Science and Technology, Luoyang, Henan, ChinaCorrespondence[email protected]
View further author information

Article: 1740477 | Received 25 Jul 2019, Accepted 22 Jan 2020, Published online: 07 Apr 2020

Cite this article
https://doi.org/10.1080/2162402X.2020.1740477
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (27)

Banglun Pan, Xiaoling Ke, Jiacheng Qiu, Dongjie Ye, Zhu Zhang, Xiaoxia Zhang, Yue Luo, Yuxin Yao, Xiaoxuan Wu, Xiaoqian Wang & Nanhong Tang. (2024) LAIR1-mediated resistance of hepatocellular carcinoma cells to T cells through a GSK-3β/β-catenin/MYC/PD-L1 pathway. Cellular Signalling 115, pages 111039.
Crossref

Shashwat Tripathi, Hinda Najem, Corey Dussold, Sebastian Pacheco, Jason Miska, Kathleen McCortney, Alicia Steffens, Jordain Walshon, Daniel Winkowski, Michael Cloney, Matthew Ordon, William Gibson, Hanna Kemeny, Mark Youngblood, Rebecca Du, James Mossner, Pavlos Texakalidis, Annelise Sprau, Matthew Tate, Charles David James, Craig M. Horbinski, Nitin R. Wadhwani, Maciej S. Lesniak, Sandi Lam, Ankita Sati, Manish Aghi, Michael DeCuypere & Amy B. Heimberger. (2024) Cancer-associated fibroblast–secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas. Journal of Clinical Investigation 134:4.
Crossref

Jimena Collado, Lauren Boland, Jared T. Ahrendsen, Jason Miska & Catalina Lee-Chang. (2024) Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy. Frontiers in Immunology 15.
Crossref

Francesca Pettinella, Barbara Mariotti, Chiara Lattanzi, Kirsten Bruderek, Marta Donini, Sara Costa, Olivia Marini, Giulia Iannoto, Sara Gasperini, Elena Caveggion, Monica Castellucci, Federica Calzetti, Francisco Bianchetto-Aguilera, Elisa Gardiman, Matteo Giani, Stefano Dusi, Maurizio Cantini, Aurora Vassanelli, Denise Pavone, Michele Milella, Sara Pilotto, Pamela Biondani, Benedikt Höing, Marie Carolin Schleupner, Timon Hussain, Boris Hadaschik, Cordelia Kaspar, Carlo Visco, Cristina Tecchio, Leo Koenderman, Flavia Bazzoni, Nicola Tamassia, Sven Brandau, Marco A. Cassatella & Patrizia Scapini. (2024) Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors. Cell Reports Medicine 5:2, pages 101380.
Crossref

Wei Du, Xueming Xia, Fan Hu & Jiayun Yu. (2024) Extracellular matrix remodeling in the tumor immunity. Frontiers in Immunology 14.
Crossref

Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli & Giuseppe Curigliano. (2024) Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting. Cancers 16:2, pages 281.
Crossref

Akashdip Singh, Eline T. A. M. Mommers-Elshof, Saskia V. Vijver, J. H. Marco Jansen, Susanne Gonder, Robert Jan Lebbink, Dominique Bihan, Richard W. Farndale, Louis Boon, Solomon Langermann, Jeanette H. W. Leusen, Dallas Flies, Linde Meyaard & M. Ines Pascoal Ramos. (2024) Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice. Cancer Immunology, Immunotherapy 73:1.
Crossref

Pavla Taborska, Pavol Lukac, Dmitry Stakheev, Lenka Rajsiglova, Katerina Kalkusova, Karolina Strnadova, Lukas Lacina, Barbora Dvorankova, Jiri Novotny, Michal Kolar, Milena Vrana, Hana Cechova, Sarka Ransdorfova, Marie Valerianova, Karel SmetanaJrJr, Luca Vannucci & Daniel Smrz. (2023) Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy. Scientific Reports 13:1.
Crossref

Xiaoqian Wei, Shushan Pan, Zirui Wang, Jieru Chen, Li Lu, Qizhi Cao, Shuling Song, Huachang Zhang, Xiaohui Liu, Xianjun Qu, Xiukun Lin & Huanli Xu. (2023) LAIR1 drives glioma progression by nuclear focal adhesion kinase dependent expressions of cyclin D1 and immunosuppressive chemokines/cytokines. Cell Death & Disease 14:10.
Crossref

Dallas B. Flies, Solomon Langermann, Christina Jensen, Morten A. Karsdal & Nicholas Willumsen. (2023) Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix. Frontiers in Immunology 14.
Crossref

Jinna Li, Qing Guo & Rui Xing. (2023) Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma. BMC Cancer 23:1.
Crossref

Ti Zhou, Luqing Liu, Haibin Lan & Donglin Fang. (2023) Effects of LAIR‐1 on hepatocellular carcinoma cell proliferation and invasion via PI3K‐AKT‐mTOR pathway regulation. Immunity, Inflammation and Disease 11:8.
Crossref

Zhennan Yuan, Yingpu Li, Sifan Zhang, Xueying Wang, He Dou, Xi Yu, Zhiren Zhang, Shanshan Yang & Min Xiao. (2023) Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Molecular Cancer 22:1.
Crossref

Zhansheng Fang, Li Lin, Zewei Tu, Xingen Zhu, Jingying Li, Pengxiang Luo, Kai Huang & Lei Wu. (2022) Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas. Cancer Medicine 12:1, pages 712-732.
Crossref

Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, Heinz Läubli & Alfred Zippelius. (2022) Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment. Science Translational Medicine 14:670.
Crossref

Reham Hammad, Reda Badr Aglan, Shaymaa A. Mohammed, Eman Abu-elnasr Awad, Marwa A. Elsaid, Hanan M. Bedair, Seham K. Khirala, Mohamed A Selim, Asmaa A. Abo Elqasem, Areej Rushdi, Mohamed Ali, Omaima I. Abo-Elkheir, Eman F. Sanad & Nadia M. Hamdy. (2022) Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma. International Journal of Molecular Sciences 23:20, pages 12541.
Crossref

Jingjing Xie, Xun Gui, Mi Deng, Heyu Chen, Yuanzhi Chen, Xiaoye Liu, Zhiqiang Ku, Lingxiao Tan, Ryan Huang, Yubo He, Bruce Zhang, Cheryl Lewis, Kenian Chen, Lin Xu, Jian Xu, Tao Huang, X. Charlene Liao, Ningyan Zhang, Zhiqiang An & Cheng Cheng Zhang. (2022) Blocking LAIR1 signaling in immune cells inhibits tumor development. Frontiers in Immunology 13.
Crossref

Silvia Muccioli, Roberto Ciaccio, Valentina Brillo & Luigi Leanza. (2022) Promising prognostic value of Transglutaminase type 2 and its correlation with tumor-infiltrating immune cells in skin cutaneous melanoma. Cell Death Discovery 8:1.
Crossref

Lucas A. Horn, Paul L. Chariou, Sofia R. Gameiro, Haiyan Qin, Masafumi Iida, Kristen Fousek, Thomas J. Meyer, Margaret Cam, Dallas Flies, Solomon Langermann, Jeffrey Schlom & Claudia Palena. (2022) Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication. Journal of Clinical Investigation 132:8.
Crossref

Irina Palacín-Aliana, Josefa Carrión-Navarro, Ángel Ayuso-Sacido & Noemí García-Romero. 2022. Translational Autoimmunity. Translational Autoimmunity 51 71 .

Anne Mette Askehøj Rømer, Marie-Louise Thorseth & Daniel Hargbøl Madsen. (2021) Immune Modulatory Properties of Collagen in Cancer. Frontiers in Immunology 12.
Crossref

Wancheng Liu, Meiling Gao, Lili Li, Yu Chen, Huimin Fan, Qiaomei Cai, Yueyue Shi, Chaohu Pan, Junxiao Liu, Lucy S. Cheng, Heng Yang & Genhong Cheng. (2021) Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagens. Cellular & Molecular Immunology 18:12, pages 2660-2672.
Crossref

Saskia V. Vijver, Akashdip Singh, Eline T. A. M. Mommers-Elshof, Jan Meeldijk, Ronald Copeland, Louis Boon, Sol Langermann, Dallas Flies, Linde Meyaard & M. Inês Pascoal Ramos. (2021) Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1. Frontiers in Immunology 12.
Crossref

Chuanchuan Zhan, Chao Xu, Jiajun Chen, Chong Shen, Jinkun Li, Zichu Wang, Xiangrong Ying, Zhengang Luo, Yu Ren, Gangfeng Wu, Haojie Zhang & Manfei Qian. (2021) Development and Validation of an IL6/JAK/STAT3-Related Gene Signature to Predict Overall Survival in Clear Cell Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref

M Ines Pascoal Ramos, Linjie Tian, Emma J de Ruiter, Chang Song, Ana Paucarmayta, Akashdip Singh, Eline Elshof, Saskia V Vijver, Jahangheer Shaik, Jason Bosiacki, Zachary Cusumano, Christina Jensen, Nicholas Willumsen, Morten A Karsdal, Linda Liu, Sol Langermann, Stefan Willems, Dallas Flies & Linde Meyaard. (2021) Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. eLife 10.
Crossref

Chitra Joseph, Mansour A. Alsaleem, Michael S. Toss, Yousif A. Kariri, Maryam Althobiti, Sami Alsaeed, Abrar I. Aljohani, Pavan L. Narasimha, Nigel P. Mongan, Andrew R. Green & Emad A. Rakha. (2020) The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma. Cancers 13:1, pages 80.
Crossref

Mira Park, Doyoen Kim, Kwanyoung Moon & Taesung Park. (2020) Integrative Analysis of Multi-Omics Data Based on Blockwise Sparse Principal Components. International Journal of Molecular Sciences 21:21, pages 8202.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1

Articles from other publishers (27)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1

Citations (27)

Articles from other publishers (27)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date